Viewing Study NCT05385705

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:37 AM

Ignite Modification Date: 2025-12-26 @ 2:20 AM

Study NCT ID: NCT05385705

Status: TERMINATED

Last Update Posted: 2025-09-22

First Post: 2022-05-17

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020

Sponsor: Vall d'Hebron Institute of Oncology

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module